Synchrony Financial

The full register, from 13F filings

The Register tab above is hand research: a dozen holders, each traced to the filing it came from. This asks the same question of the whole market for the quarter ended 31-mar-2026, where 947 managers reported a position. Broad where the research is deep, and shallow in the ways a 13F always is.

Built from 13F filings, which report US listed, long, US custodied positions only. A register from this source is a floor rather than a level: a holder's true position can be far larger, as BlackRock's ASML stake shows at 1.28m shares in a 13F against 26.3m in its 13G/A. Holdings held through derivatives, outside US custody, or below a manager's reporting obligation do not appear. Where a holder is marked as a family, its total sums several separate filing entities and describes something no single filing describes; the constituent entities and their share counts are listed so the total can be checked. That roll-up can legitimately exceed the family's own Schedule 13G, because a 13G is filed by one legal entity: Vanguard reports Alphabet through ten advisory entities, and The Vanguard Group Inc itself reported zero after its January 2026 disaggregation.

What a reader needs to know to read these numbers

• Synchrony Financial does NOT file a 13F. Its full SEC filing history (form types on CIK 0001601712) contains no 13F-HR or 13F-NT, only 10-K, 10-Q, 8-K, DEF 14A, 424B5/S-3ASR/S-8, and Schedule 13G/13G-A filings made ABOUT Synchrony by others (insiders' Forms 3/4/5, and 13G filers reporting stakes IN Synchrony). As a bank holding company Synchrony has no asset-management arm that would file its own 13F, so the client-assets exclusion issue (e.g. JPMorgan) does not arise here: there is simply no 13F to consider excluding.
• company.shares_outstanding (325,370,840) is COMMON shares only, per the cover page of the 10-Q for the quarter ended 30 Jun 2026 ('shares of the registrant's common stock, par value $0.001 per share, outstanding as of July 17, 2026 was 325,370,840'). Synchrony also has listed 5.15% and 5.625% Fixed Rate Non-Cumulative Perpetual Preferred Stock, each represented by NYSE-listed depositary shares (tickers SYF-PA, SYF-PB). No preferred or depositary-share CUSIP was found on any 13F pulled for this file: every register row above was verified against the common-stock CUSIP 87165B103 by the filing.py 13f tool, which groups by CUSIP. No preferred position is counted into any register row.
• Register basis is the FRESH Q2 2026 (period 30 Jun 2026) 13F-HR information table for every institutional holder, fetched directly from each filer's own EDGAR filing, not from this project's data/registers/SYF.json snapshot (which is a 31 Mar 2026 snapshot used only to enumerate WHICH entities to check). The snapshot was missing T. Rowe Price and FMR/Fidelity entirely; both were found holding SYF by checking their own CIKs directly and are included above as new rows.
• Vanguard: the parent 'THE VANGUARD GROUP INC' (CIK 0000102909) filed Form 13F-NT (a notice carrying no holdings) for Q2 2026, so its position is reported entirely through successor entities. All 8 successor entities on file were checked individually for Q2 2026 (Vanguard Fiduciary Trust Co, Vanguard Investments Australia, Vanguard Asset Management Ltd, Vanguard Personalized Indexing Management LLC, Vanguard Global Advisers LLC, Vanguard National Trust Co, Vanguard Capital Management LLC, Vanguard Portfolio Management LLC) and SUMMED to 43,920,489 shares / $3,340,153,188, per the PNC-style rule for an absent 13F-NT parent.
• Capital Group: checked all 6 known Capital Group registrant CIKs (Capital World Investors, Capital International Investors, Capital Research Global Investors, Capital International Inc/CA, Capital International Ltd/CA, Capital International Sarl). Only two held SYF as of 30 Jun 2026: Capital World Investors (18,918,854 sh) and Capital International Sarl (37,198 sh), summing to 18,956,052 sh / $1,441,607,755. This is a family roll-up, not a proxy aggregate; is_aggregate is NOT set on it because nothing rolls into it.
• T. Rowe Price: checked both registrants (T. Rowe Price Associates, Inc., CIK 0000080255, and T. Rowe Price Investment Management, Inc., CIK 0001897612). Only Associates held SYF (638,795 sh); Investment Management held zero. T. Rowe's infotable reports VALUES IN THOUSANDS: the raw XML value field read 48,581, which was multiplied by 1,000 to $48,581,000 before use. Implied price check: $48,581,000 / 638,795 sh = $76.06/share, consistent with the ~$76/share implied by every other Q2 2026 13F pulled for this file (BlackRock $76.05, Vanguard family $76.04, FMR $76.05, T. Rowe $76.06), confirming the thousands conversion is correct.
• Stale-13G reconciliation from the DEF 14A filed 29 Apr 2026 (5% owners table, based on 336,811,219 shares outstanding as of 1 Apr 2026, before subsequent buybacks reduced the count to 325,370,840 by 17 Jul 2026): Capital World Investors 44,534,680 sh / 13.22% from a Schedule 13G/A as of 29 Dec 2023 (over 2 years stale); BlackRock 35,218,825 sh / 10.46% from a Schedule 13G/A as of 31 Dec 2024; State Street 19,080,903 sh / 5.67% from a Schedule 13G/A as of 30 Sep 2025. All three were superseded here by fresher Q2 2026 13F-HR figures per the brief's rule to prefer the fresh 13F, and all three fresh figures came in LOWER than the stale 13G ones (correction ran the same direction for all three in this case, which the brief warns not to assume in general).
• Insider side: the DEF 14A beneficial ownership table (as of 1 Apr 2026) shows no founder or controlling insider position; CEO Brian D. Doubles holds 587,452 shares (0.18%) and 'All directors and executive officers as a group (21 persons)' holds 1,200,851 shares (0.37% unreduced). Doubles is marked rolls_up_into the group row to avoid double counting per the overlap rule; every other individually named officer/director in the proxy (Carol Juel, Curtis Howse, Jonathan S. Mothner, Brian J. Wenzel Sr., and all 11 independent directors) holds well under 100,000 shares each and was not given its own row, consistent with 'anything strategic at any size' not applying to any of them.
• Equity method investments: FY2025 10-K and the Q2 2026 10-Q both report a single combined 'Equity method investments' balance in Other assets ($841 million at 30 Jun 2026, $834 million at 31 Dec 2025) with no per-investee breakdown disclosed anywhere in either filing. The only investee identified BY NAME is Independence Pet Holdings, Inc. (IPH), sized separately at its $605 million acquisition-date fair value (see holdings). The remaining roughly $229-236 million of the combined balance is NOT attributable to any named investee and is left out of holdings per the 'never assign a combined balance to one investee' rule; that residual is recorded as unknown below.
• Versatile Credit, Inc. (acquired October 2025) is a wholly owned operating subsidiary, not an equity-method or minority stake, and is excluded from holdings per the brief.
• Exhibit 21 (list of subsidiaries) to the FY2025 10-K was checked and contains no ownership-percentage column and no mention of Independence Pet Holdings or any other equity-method investee; it is a bare list of wholly owned subsidiaries, so it did not help size any holding. Treated as a genuine negative rather than evidence of a missed source.
• Self-gate computed from this final file, using the chart's exact arithmetic (aggregate row reduced by its rolls_up_into member, everything else at full value): 11 register rows, 142,072,697 shares, 43.66% of shares_outstanding (325,370,840). Within the expected 25-45% band.